Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
2017 Startups to Watch
stats here
Related Posts on Startland News
Coming UMKC innovation center to serve students, entrepreneurs
With funding shored up from private and public donors, the University of Missouri-Kansas City is planning to move ahead with its plan to build the Robert W. Plaster Free Enterprise Center to support students and entrepreneurs. Missouri Gov. Jay Nixon announced Tuesday that the state is allocating $7.4 million to the center, which represents half…
Security firm Nodal nabs $100K, ramps up hiring
Good news is stacking up for Kansas City-based Nodal Industries. The security hardware tech company recently snagged $100,000 in seed funding as part of an opportunity to participate in the 500 Startup accelerator program, based in Mountain View, Calif. The funding will allow Nodal to hire up to eight people, as well as ramp up production…
Play-It Health lands in top-ranked digital health accelerator
As with many successful startups, the idea for Play-It Health was born out of personal experience with an unsolved industry need. Kim Gandy, a former clinician and now the founder and CEO of Play-It Health, recognized that patients were having trouble engaging and adhering to their medical regimen. In the worst cases, this led to…
LaunchKC, Techweek to welcome 10 tech firms to KC in style
In roughly four months, Kansas City will welcome a crop of tech startups bolstered by thousands of dollars in funding and a rockstar arrival. Kansas City’s LaunchKC competition — which aims to attract 10 tech firms to relocate to KC with $50,000 grants — has partnered with national tech conference Techweek to offer the winners…